ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      18,998.74
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.875
      -2.62%
      Bitcoin
      67,018.91
      4.77%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Humacyte Inc (HUMAW)

      7. Humacyte Inc (HUMAW) Financials

      Humacyte Inc

      Humacyte Inc (HUMAW)

      NASDAQ
      2.7286
      -0.0339
      (-1.23%)
      At close: July 19 4:00PM
      Delayed by 15 minutes
      2.80
      0.0714
      ( 2.62% )
      After Hours: 5:00PM
      Delayed by 15 minutes

      Humacyte Inc Financial Summary

      The current HUMAW market cap is 578.42M. The company's latest EPS is USD -0.5362 and P/E is -20.44.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -22.51M-26.73M-24.62M-26.18M-26.58M
      Net Income -36.97M-22.71M-26M-25.11M-31.9M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 01.26M1.57M0
      Operating Income -249k-81.26M-84.58M-100.05M
      Net Income -233k-26.48M-11.97M-110.78M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 182.98M168.11M149.39M128.22M161.47M
      Total Liabilities 101.09M106.99M112.39M114.68M135.31M
      Total Equity 81.89M61.12M36.99M13.55M26.15M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 101.26M286.53M204.3M128.22M
      Total Liabilities 2.1M164.36M87.37M114.68M
      Total Equity 5M122.17M116.93M13.55M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -18.64M-41.24M-54.25M-73.31M-27.35M
      Investing -1.15M470k-23k-173k-391k
      Financing -409k5.61M4.84M4.51M62.8M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -245k-81.19M-71.13M-73.31M
      Investing -100M-8.22M4.85M-173k
      Financing 101.34M266.98M-1.45M4.51M

      Stats and Ratios

      Market Cap 578.42M
      Price to Earnings Ratio -20.44
      Price to Sales Ratio 0
      Price to Cash Ratio 28.15
      Price to Book Ratio 167.14
      Dividend Yield -

      Share Statistics

      Shares Outstanding 206.58M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.25 (8.93%)

      Company Info

      Company Name Humacyte Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.humacyte.com
      Industry biological pds,ex diagnstics (2836)